Table 5: The adjusted value of P-gp/TBB5 (`X±SD).

Group

1

2

3

4

5

6

7

P-gp/TBB5

1

6.03±0.77a

6.33±0.66a

5.50±0.28a

2.96±0.99ab

5.44±1.54a

4.29±0.96ab

NoteGroup: 1: K562, K562 cell control group; 2: K562/ADM, K562/ADM cell control group; 3: K562/ADM+A, K562/ADM cells were treated with ADM for 48h; 4: K562/ADM+A+T, K562/ADM cells, first added ADM for 48 h, then added TTD for 48 h; 5:K562/ADM+T, K562/ADM cells were treated with TTD for 48h; 6:K562/ADM+T+A, K562/ADM cells, first added TTD for 48 h, then added ADM for 48 h; 7:K562/ADM+AT, ADM and TTD were simultaneously applied to K562/ADM cells for 48h. Compared with group K562, ap<0.05; Compared with group K562/ADM, bp<0.05.